I proposed to examine inconsistency for the medication outcomes which have demanded I2 statistics (when the I2 is > 50%)

I proposed to examine inconsistency for the medication outcomes which have demanded I2 statistics (when the I2 is > 50%)

I prepared pooled analyses irrespective of mathematically high heterogeneity. Alternatively, we advised investigating heterogeneity with a great priori outlined diligent features, age. Once the post hoc analyses regarding statistical strength is not required[47-50], we downgraded the quality of facts to have imprecision based on a keen projected priori max advice size in an adequately pushed RCT (age. Continue reading “I proposed to examine inconsistency for the medication outcomes which have demanded I2 statistics (when the I2 is > 50%)”